Clinical Research Directory
Browse clinical research sites, groups, and studies.
Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany
Sponsor: Novo Nordisk A/S
Summary
This study aims to generate structured patient preference evidence on prophylactic treatment options for haemophilia A for adults with and without inhibitors to support health technology assessment and benefit evaluation processes. The study will examine how individuals with haemophilia A evaluate trade-offs between treatment effectiveness, safety, and treatment administration characteristics when choosing between prophylactic therapies. Participants will repeatedly choose between hypothetical treatment profiles that differ in clinically relevant attributes and levels.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2026-07-10
Completion Date
2026-10-26
Last Updated
2026-06-17
Healthy Volunteers
No
Conditions
Interventions
No treatment given
Web-based survey
Locations (1)
Novo Nordisk Investigational Site
Mainz, Gonsenheim, Germany